Are you Dr. Durvasula?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 50 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4500 San Pablo Road S
Jacksonville, FL 32224Phone+1 904-953-2000- Is this information wrong?
Summary
- Dr. Ravi Durvasula, MD is an infectious disease specialist in Jacksonville, Florida. He is currently licensed to practice medicine in Florida, Illinois, and New Mexico. He is affiliated with Mayo Clinic Hospital in Florida and is a Professor at University of New Mexico School of Medicine.
Education & Training
- Yale-New Haven Medical CenterFellowship, Infectious Disease, 1993 - 1996
- Baylor College of MedicineResidency, Internal Medicine, 1989 - 1992
- McGill University Faculty of MedicineClass of 1989
Certifications & Licensure
- FL State Medical License 2021 - 2025
- IL State Medical License 2018 - 2023
- NM State Medical License 2014 - 2018
- CT State Medical License 1992 - 2015
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2009
Clinical Trials
- CYP19A1 (Cytochrome P450 Family 19 Subfamily A Member 1) Gene and Pharmacogenetics of Response to Testosterone Therapy Start of enrollment: 2011 Oct 01
Publications & Presentations
PubMed
- Rapid Generation and Molecular Docking Analysis of Single-Chain Fragment Variable (scFv) Antibody Selected by Ribosome Display Targeting Cholecystokinin B Receptor (CC...Adinarayana Kunamneni, Marena A Montera, Ravi Durvasula, Sascha R A Alles, Sachin Goyal, Karin N Westlund> ;International Journal of Molecular Sciences. 2023 Jul 3
- 7 citationsNeurophenotypes of COVID-19: Risk factors and recovery outcomes.Divya Prabhakaran, Gregory S Day, Bala Munipalli, Beth K Rush, Lauren Pudalov, Shehzad K Niazi, Emily Brennan, Harry R Powers, Ravi Durvasula, Arjun Athreya, Karen Bla...> ;Brain, Behavior, & Immunity - Health. 2023 Jul 1
- Mycolactone: A Broad Spectrum Multitarget Antiviral Active in the Picomolar Range for COVID-19 Prevention and Cure.Seth Osei Asiedu, Yash Gupta, Vlad Nicolaescu, Haley Gula, Thomas R Caulfield, Ravi Durvasula, Prakasha Kempaiah, Samuel K Kwofie, Michael D Wilson> ;International Journal of Molecular Sciences. 2023 Apr 12
- Join now to see all
Press Mentions
- Why New York Gyms Say They Can Reopen SafelyAugust 11th, 2020
- NYS Fitness Alliance Sends Detailed Safety Protocols to New York State for Approval on Gym ReopeningAugust 6th, 2020
- Groundbreaking Study Could Lead to Fast, Simple Test for Ebola VirusMay 7th, 2019
- Join now to see all
Grant Support
- T. Cruzi Molecular Targets For Vector ParatransgenesisNational Institute Of Allergy And Infectious Diseases2007–2010
- A Strategy For Spreading Genes In Chagas Disease VectorsNational Institute Of Allergy And Infectious Diseases2001–2004
Hospital Affiliations
- Mayo Clinic Hospital in FloridaJacksonville, Florida